Author Archive | David Ahn, MD (@AhnCall)
Guide to cheaper but high quality alternatives to every Fitbit product.
Dexcom received FDA approval for the first iPhone app that can receive glucose information directly from a continuous glucose monitor (CGM).
A recent flurry of FDA approvals suggests a higher priority on speeding the pace of innovation.
An innovative app that helps diabetic patients understand how different foods affect their glucose levels
Dexcom showcased the future of diabetes data streaming directly to the iPhone and Apple Watch.
The MeterSync Blue enables wireless transfer of glucose readings from over 30 supported glucose meters to iPhone and Android.
These cleverly designed smart ear plugs take a completely different approach to sleep
Figure 1, a medical photo sharing network that we’ve covered previously, recently pushed out a new update to their iOS and Android apps that should significantly improve the user experience. With version 5.0, Figure 1 now allows users to filter which content categories populate their home feed. For example, a user might prefer to focus […]
Pact Health introduces a health plan that saves users up to $1300 on their deductible for healthy behaviors.
Dexcom’s new glucose in the cloud solution reveals FDA approval challenges
Fitbit’s new activity trackers will contain high level features, possibly recruiting elite athletes.
The looming Apple Watch has the wearable health market responding with a flurry of activity.
Physicians who use Citrix to access their EMR on their iPads should be wary of updating to iOS8
The Verio Sync glucose meter is a classic example of hardware and software not meshing.
The Apple Watch presents an opportunity to change the way diabetes is monitored.
The Abbott Fresstyle Libre Flash promises to eliminate painful fingersticks and pricks.
The Telcare BGM adds cellular and wireless connectivity to the cloud
The Sense System has raised over $1.5 million on Kickstarter but fails to incorporate basic sleep medicine principles.
Novartis’ gives medical credibility to Google’s glucose-sensing contact lens.